The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-08-25
DOI
10.3389/fendo.2022.918869
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Functional Role of Extracellular Matrix Proteins in Cancer
- (2022) Nadezhda V. Popova et al. Cancers
- Myeloid-Derived Suppressor Cells in Solid Tumors
- (2022) Tianmiao Ma et al. Cells
- c-Met-targeted chimeric antigen receptor T cells inhibit hepatocellular carcinoma cells in vitro and in vivo
- (2022) Xiaochen Huang et al. Journal of Biomedical Research
- Cancer associated fibroblast–derived CCL5 promotes hepatocellular carcinoma metastasis through activating HIF1α/ZEB1 axis
- (2022) Haixu Xu et al. Cell Death & Disease
- Myeloid-derived suppressor cells promote tumor growth and sorafenib resistance by inducing FGF1 upregulation and fibrosis
- (2022) Xue Deng et al. NEOPLASIA
- Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy
- (2022) Xin Liu et al. Journal for ImmunoTherapy of Cancer
- The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature
- (2021) Jan Korbecki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Anti‐tumor efficacy of human anti‐c‐met CAR‐T cells against papillary renal cell carcinoma in an orthotopic model
- (2021) Jun‐ich Mori et al. CANCER SCIENCE
- Cancer‐associated fibroblast‐mediated cellular crosstalk supports hepatocellular carcinoma progression
- (2021) Mengjia Song et al. HEPATOLOGY
- Bispecific c-Met/PD-L1 CAR-T Cells Have Enhanced Therapeutic Effects on Hepatocellular Carcinoma
- (2021) Wei Jiang et al. Frontiers in Oncology
- In Situ Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular Carcinoma
- (2021) Isabella Lurje et al. Frontiers in Immunology
- Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma
- (2021) Luan Sun et al. Journal for ImmunoTherapy of Cancer
- MUC1: Structure, Function, and Clinic Application in Epithelial Cancers
- (2021) Wenqing Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review
- (2021) Kyoko Oura et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin
- (2021) Nengzhi Pang et al. Journal of Hematology & Oncology
- Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B
- (2021) Yanan Gao et al. JOURNAL OF HEPATOLOGY
- A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
- (2021) Prasad S Adusumilli et al. Cancer Discovery
- Combination of AAV-CCL19 and GPC3 CAR-T Cells in the Treatment of Hepatocellular Carcinoma
- (2021) Min Meng et al. Journal of Immunology Research
- Tumor-Associated Neutrophils in Hepatocellular Carcinoma Pathogenesis, Prognosis, and Therapy
- (2021) Konstantinos Arvanitakis et al. Cancers
- Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation
- (2021) Yufei Yan et al. Biomedicines
- Pathogenicity of the MAGE family (Review)
- (2021) Sanyan Li et al. Oncology Letters
- Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer
- (2021) Saisha A Nalawade et al. Journal for ImmunoTherapy of Cancer
- c-Met-Specific Chimeric Antigen Receptor T Cells Demonstrate Anti-Tumor Effect in c-Met Positive Gastric Cancer
- (2021) Chung Hyo Kang et al. Cancers
- Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma
- (2021) Pil Soo Sung Clinical and Molecular Hepatology
- Hepatocellular Carcinoma Tumor Microenvironment and Its Implications in Terms of Anti-tumor Immunity: Future Perspectives for New Therapeutics
- (2021) Basri Satilmis et al. Journal of Gastrointestinal Cancer
- CXCR2‐modified CAR‐T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma
- (2020) Guangna Liu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Intratumoral heterogeneity and clonal evolution in liver cancer
- (2020) Bojan Losic et al. Nature Communications
- Hepatic stellate cells promote the progression of hepatocellular carcinoma through microRNA-1246-RORα-Wnt/β-Catenin axis
- (2020) Jin-Long Huang et al. CANCER LETTERS
- Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase 1 Trials
- (2020) Donghua Shi et al. CLINICAL CANCER RESEARCH
- Tumor-associated macrophages
- (2020) Luca Cassetta et al. CURRENT BIOLOGY
- Regulatory myeloid cells paralyze T cells through cell–cell transfer of the metabolite methylglyoxal
- (2020) Tobias Baumann et al. NATURE IMMUNOLOGY
- SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo
- (2020) Chi-Neu Tsai et al. ONCOGENE
- Hepatic Stellate Cell–Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis
- (2020) Michitaka Matsuda et al. SEMINARS IN LIVER DISEASE
- EpCAM-high liver cancer stem cells resist natural killer cell–mediated cytotoxicity by upregulating CEACAM1
- (2020) Dong Jun Park et al. Journal for ImmunoTherapy of Cancer
- Engineering CAR-T Cells for Next-Generation Cancer Therapy
- (2020) Mihe Hong et al. CANCER CELL
- Interaction with CD68 and regulation of GAS6 expression by endosialin in fibroblasts drives recruitment and polarization of macrophages in hepatocellular carcinoma
- (2020) Fa Yang et al. CANCER RESEARCH
- The roles of tumor-associated macrophages in tumor angiogenesis and metastasis
- (2020) Luo-Qin Fu et al. CELLULAR IMMUNOLOGY
- The role of alpha-fetoprotein in hepatocellular carcinoma drug resistance
- (2020) Wei Li et al. CURRENT MEDICINAL CHEMISTRY
- New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma
- (2020) Michele Dal Bo et al. DRUG RESISTANCE UPDATES
- Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma
- (2020) Chang Gon Kim et al. JOURNAL OF HEPATOLOGY
- Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1/PD-1 axis
- (2020) Rui Sun et al. Translational Oncology
- Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma
- (2020) Hsiang-chi Tseng et al. Nature Communications
- New advances in the diagnosis and management of hepatocellular carcinoma
- (2020) Ju Dong Yang et al. BMJ-British Medical Journal
- Cancer-Associated Fibroblasts: Versatile Players in the Tumor Microenvironment
- (2020) Debolina Ganguly et al. Cancers
- Hepatic stellate cells in hepatocellular carcinoma promote tumor growth via growth differentiation factor 15 production
- (2020) Yuta Myojin et al. GASTROENTEROLOGY
- Tumor-Associated Macrophages in Tumor Immunity
- (2020) Yueyun Pan et al. Frontiers in Immunology
- Neutrophils as Orchestrators in Tumor Development and Metastasis Formation
- (2020) Lydia Kalafati et al. Frontiers in Oncology
- Tumor Neovascularization and Developments in Therapeutics
- (2019) Yuki Katayama et al. Cancers
- The effect of hepatic stellate cells on hepatocellular carcinoma progression.
- (2019) Shuichi Iwahashi et al. JOURNAL OF CLINICAL ONCOLOGY
- Blocking TREM-1+ Tumor-associated macrophages induced by hypoxia reverses immunosuppression and anti-PD-L1 resistance in liver cancer
- (2019) Qinchuan Wu et al. HEPATOLOGY
- Fibroblast Growth Factor-2 Binding to Heparan Sulfate Proteoglycans Varies with Shear Stress in Flow-Adapted Cells
- (2019) Jonathan Garcia et al. ANNALS OF BIOMEDICAL ENGINEERING
- M2 macrophages mediate sorafenib resistance by secreting HGF in a feed-forward manner in hepatocellular carcinoma
- (2019) Ningning Dong et al. BRITISH JOURNAL OF CANCER
- Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma
- (2019) Man Liu et al. GUT
- RIP 3 deficiency recruits myeloid‐derived suppressor cells to hepatocellular carcinoma through the CXCL 1‐ CXCR 2 axis
- (2019) Yi‐Ming Li et al. HEPATOLOGY
- A Positive Feedback Loop Between Cancer Stem‐Like Cells and Tumor‐Associated Neutrophils Controls Hepatocellular Carcinoma Progression
- (2019) Shao‐Lai Zhou et al. HEPATOLOGY
- Regulation of regulatory T cells in cancer
- (2019) Julie Stockis et al. IMMUNOLOGY
- Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma
- (2019) Yohei Mano et al. JOURNAL OF GASTROENTEROLOGY
- Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3–Targeted Chimeric Antigen Receptor–Engineered T Cells in Hepatocellular Carcinoma
- (2019) Ying Liu et al. JOURNAL OF IMMUNOLOGY
- CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
- (2019) Ru Zhou et al. Frontiers in Immunology
- Collagen 1A1 (COL1A1) Is a Reliable Biomarker and Putative Therapeutic Target for Hepatocellular Carcinogenesis and Metastasis
- (2019) Hon-Ping Ma et al. Cancers
- Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment
- (2019) Tianyi Liu et al. Frontiers in Cell and Developmental Biology
- Downregulation of exosomal CLEC3B in hepatocellular carcinoma promotes metastasis and angiogenesis via AMPK and VEGF signals
- (2019) Wenjuan Dai et al. Cell Communication and Signaling
- From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
- (2019) Yaojie Fu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities
- (2019) Chen Lu et al. Molecular Cancer
- Eradication of Hepatocellular Carcinoma by NKG2D-Specific CAR-T Cells
- (2019) Bin Sun et al. Cancer Immunology Research
- Activated hepatic stellate cells promote angiogenesis in hepatocellular carcinoma by secreting angiopoietin‐1
- (2019) Nan Lin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- NY-ESO-1 expression in solid tumors predicts prognosis
- (2019) Huiyu Wang et al. MEDICINE
- CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors
- (2019) Linchun Jin et al. Nature Communications
- CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker
- (2019) Alexandra Landras et al. Cancers
- Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy
- (2019) Ren-Yu Zhang et al. Frontiers in Cell and Developmental Biology
- Acetylation of alpha-fetoprotein promotes hepatocellular carcinoma progression
- (2019) Junhui Xue et al. CANCER LETTERS
- TMPRSS4 Drives Angiogenesis in Hepatocellular Carcinoma by Promoting HB‐EGF Expression and Proteolytic Cleavage
- (2019) Zhao‐Ru Dong et al. HEPATOLOGY
- Th17, synchronically increased with Tregs and Bregs , promoted by tumour cells via cell-contact in primary hepatic carcinoma
- (2018) W. Wang et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Plasticity of myeloid-derived suppressor cells in cancer
- (2018) Evgenii Tcyganov et al. CURRENT OPINION IN IMMUNOLOGY
- Both glypican-3/Wnt/β-catenin signaling pathway and autophagy contributed to the inhibitory effect of curcumin on hepatocellular carcinoma
- (2018) Pei Hu et al. DIGESTIVE AND LIVER DISEASE
- Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma
- (2018) Mohamed Bouattour et al. HEPATOLOGY
- Redirection to the bone marrow improves T cell persistence and antitumor functions
- (2018) Anjum B. Khan et al. JOURNAL OF CLINICAL INVESTIGATION
- Prognostic significance of glypican-3 expression in hepatocellular carcinoma
- (2018) Hong Liu et al. MEDICINE
- Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication
- (2018) Christopher C. Kloss et al. MOLECULAR THERAPY
- A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects
- (2018) Yuki Kagoya et al. NATURE MEDICINE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma
- (2018) Yusheng Cheng et al. Cell Death & Disease
- Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway
- (2018) Meng-He Wang et al. Cell Death & Disease
- CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
- (2018) Yao Wang et al. OncoImmunology
- Overexpression of epithelial cell adhesion molecule as a predictor of poor outcome in patients with hepatocellular carcinoma
- (2018) Chih‑Jan Ko et al. Experimental and Therapeutic Medicine
- FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia
- (2018) Maura C. O’Leary et al. CLINICAL CANCER RESEARCH
- FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma
- (2018) Najat Bouchkouj et al. CLINICAL CANCER RESEARCH
- CD4+ CD25+ regulatory T cells promote hepatocellular carcinoma invasion via TGF-β1-induced epithelial–mesenchymal transition
- (2018) Chunying Shi et al. OncoTargets and Therapy
- Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma
- (2018) Xingliang Guo et al. Frontiers in Pharmacology
- Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1+ regulatory B cell expansion
- (2018) Linsen Ye et al. Journal for ImmunoTherapy of Cancer
- Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity
- (2017) Wenpeng Li et al. HUMAN GENE THERAPY
- High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma
- (2017) Youping Wei et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Mechanisms of hepatic stellate cell activation
- (2017) Takuma Tsuchida et al. Nature Reviews Gastroenterology & Hepatology
- The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma
- (2017) O Govaere et al. ONCOGENE
- Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma
- (2017) David Kung-Chun Chiu et al. Nature Communications
- Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer
- (2017) Julia Tchou et al. Cancer Immunology Research
- Critical Role of Myeloid-Derived Suppressor Cells in Tumor-Induced Liver Immune Suppression through Inhibition of NKT Cell Function
- (2017) Hongru Zhang et al. Frontiers in Immunology
- Regional Delivery of Chimeric Antigen Receptor (CAR) T-Cells for Cancer Therapy
- (2017) et al. Cancers
- Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer
- (2016) Hong Liu et al. CLINICAL CANCER RESEARCH
- Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
- (2016) Jiangtao Ren et al. CLINICAL CANCER RESEARCH
- Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib
- (2016) Shao-Lai Zhou et al. GASTROENTEROLOGY
- Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26
- (2016) David Kung-Chun Chiu et al. HEPATOLOGY
- MAGE-A is More Highly Expressed Than NY-ESO-1 in a Systematic Immunohistochemical Analysis of 3668 Cases
- (2016) Sid P. Kerkar et al. JOURNAL OF IMMUNOTHERAPY
- Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells – evidence for a role in hepatocellular carcinoma growth in vivo
- (2016) Franziska Mußbach et al. Molecular Cancer
- Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells
- (2016) Y Deng et al. ONCOGENE
- Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2
- (2016) Yaping Xu et al. Oncotarget
- Interleukin-6-stimulated progranulin expression contributes to the malignancy of hepatocellular carcinoma cells by activating mTOR signaling
- (2016) Feng Liu et al. Scientific Reports
- Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation
- (2016) J-t Cheng et al. Oncogenesis
- Peritumoral stromal neutrophils are essential for c-Met-elicited metastasis in human hepatocellular carcinoma
- (2016) Min He et al. OncoImmunology
- Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome
- (2016) Linan Wang et al. OncoImmunology
- Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T
- (2015) Rachel A. Burga et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin
- (2015) Jin Song et al. CANCER LETTERS
- A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection
- (2015) David Y Zhang et al. GUT
- Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma
- (2015) Juling Ji et al. HEPATOLOGY
- Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells
- (2015) Qiongshu Li et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- High preoperative levels of serum glypican-3 containing N-terminal subunit are associated with poor prognosis in patients with hepatocellular carcinoma after partial hepatectomy
- (2015) Yukihiro Haruyama et al. INTERNATIONAL JOURNAL OF CANCER
- CXCR2–CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma
- (2015) Li Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
- (2015) Gaixia He et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Increased autophagy sustains the survival and pro-tumourigenic effects of neutrophils in human hepatocellular carcinoma
- (2015) Xue-Feng Li et al. JOURNAL OF HEPATOLOGY
- Hepatic Stellate Cells Inhibit T Cells through Active TGF-β1 from a Cell Surface–Bound Latent TGF-β1/GARP Complex
- (2015) Yan Li et al. JOURNAL OF IMMUNOLOGY
- Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes
- (2015) Ignazio Caruana et al. NATURE MEDICINE
- TIMP-1 activated carcinoma-associated fibroblasts inhibit tumor apoptosis by activating SDF1/CXCR4 signaling in hepatocellular carcinoma
- (2015) Tao Song et al. Oncotarget
- NKG2D Ligands in Tumor Immunity: Two Sides of a Coin
- (2015) Jinyu Zhang et al. Frontiers in Immunology
- Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway
- (2014) Yan Shao et al. CANCER LETTERS
- Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
- (2014) H. Gao et al. CLINICAL CANCER RESEARCH
- Human hepatocellular carcinoma-infiltrating CD4+CD69+Foxp3− regulatory T cell suppresses T cell response via membrane-bound TGF-β1
- (2014) Yanmei Han et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Hepatic stellate cells promote tumor progression by enhancement of immunosuppressive cells in an orthotopic liver tumor mouse model
- (2013) Wenxiu Zhao et al. LABORATORY INVESTIGATION
- Human Hepatic Stellate Cells Inhibit T-Cell Response Through B7-H1 Pathway
- (2013) Ronald Charles et al. TRANSPLANTATION
- Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells
- (2012) Zu-Yau Lin et al. BIOMEDICINE & PHARMACOTHERAPY
- Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis
- (2012) Giray Bozkaya et al. Molecular Cancer
- Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO
- (2011) Tuanjie Li et al. CANCER LETTERS
- Role of the microenvironment in hepatocellular carcinoma development and progression
- (2011) Sheng-Di Wu et al. CANCER TREATMENT REVIEWS
- Epithelial cell adhesion molecule expression (CD326) in cancer: A short review
- (2011) Carlo Patriarca et al. CANCER TREATMENT REVIEWS
- Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
- (2010) W. Zhang et al. CLINICAL CANCER RESEARCH
- The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation
- (2010) Jin-Ping Lai et al. HEPATOLOGY
- Intratumoral neutrophils: A poor prognostic factor for hepatocellular carcinoma following resection
- (2010) Yi-Wei Li et al. JOURNAL OF HEPATOLOGY
- Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma
- (2010) Dong-Ming Kuang et al. JOURNAL OF HEPATOLOGY
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
- (2009) Zvi G. Fridlender et al. CANCER CELL
- Kupffer Cell Suppression of CD8+ T Cells in Human Hepatocellular Carcinoma Is Mediated by B7-H1/Programmed Death-1 Interactions
- (2009) K. Wu et al. CANCER RESEARCH
- Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
- (2009) M. K. Srivastava et al. CANCER RESEARCH
- Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma
- (2009) Thomas Amann et al. CANCER SCIENCE
- Human Hepatocellular Carcinoma Tumor-derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial Cells
- (2009) Y.-Q. Xiong et al. CLINICAL CANCER RESEARCH
- Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor
- (2009) Bastian Hoechst et al. HEPATOLOGY
- Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients
- (2009) Jia Zhou et al. INTERNATIONAL JOURNAL OF CANCER
- Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients
- (2009) Jing-Ping Zhang et al. JOURNAL OF HEPATOLOGY
- Nuclear signalling by tumour-associated antigen EpCAM
- (2009) Dorothea Maetzel et al. NATURE CELL BIOLOGY
- Transforming Growth Factor- 1 and CD105 Promote the Migration of Hepatocellular Carcinoma-Derived Endothelium
- (2008) A. Benetti et al. CANCER RESEARCH
- Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets
- (2008) Jin-Ping Lai et al. Future Oncology
- Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma
- (2008) Jin-Ping Lai et al. HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started